Free Trial

Schroder Income Growth (SCF) Competitors

GBX 292
-1.00 (-0.34%)
(As of 07/12/2024 ET)

SCF vs. BBH, JESC, TFIF, SYNC, TMPL, APAX, BGSC, NBPE, VOF, and ESCT

Should you be buying Schroder Income Growth stock or one of its competitors? The main competitors of Schroder Income Growth include Bellevue Healthcare (BBH), JPMorgan European Smaller Companies Trust (JESC), TwentyFour Income (TFIF), Syncona (SYNC), Temple Bar (TMPL), Apax Global Alpha (APAX), BMO Global Smaller Companies (BGSC), NB Private Equity Partners (NBPE), VinaCapital Vietnam Opp Fund (VOF), and The European Smaller Companies Trust (ESCT). These companies are all part of the "asset management" industry.

Schroder Income Growth vs.

Schroder Income Growth (LON:SCF) and Bellevue Healthcare (LON:BBH) are both small-cap financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, community ranking, dividends, analyst recommendations, institutional ownership and valuation.

Bellevue Healthcare received 44 more outperform votes than Schroder Income Growth when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 67.68% of users gave Schroder Income Growth an outperform vote.

CompanyUnderperformOutperform
Schroder Income GrowthOutperform Votes
67
67.68%
Underperform Votes
32
32.32%
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%

In the previous week, Schroder Income Growth's average media sentiment score of 0.00 equaled Bellevue Healthcare'saverage media sentiment score.

Company Overall Sentiment
Schroder Income Growth Neutral
Bellevue Healthcare Neutral

Schroder Income Growth has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Schroder Income Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schroder Income Growth£18.73M10.83£16.26M£0.231,269.57
Bellevue HealthcareN/AN/AN/A£0.16911.25

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Schroder Income Growth
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Bellevue Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Schroder Income Growth pays an annual dividend of GBX 14 per share and has a dividend yield of 4.8%. Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.1%. Schroder Income Growth pays out 6,087.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bellevue Healthcare pays out 3,750.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Schroder Income Growth has a net margin of 86.82% compared to Bellevue Healthcare's net margin of 0.00%. Schroder Income Growth's return on equity of 7.50% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Schroder Income Growth86.82% 7.50% 4.32%
Bellevue Healthcare N/A N/A N/A

10.8% of Schroder Income Growth shares are held by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are held by institutional investors. 2.6% of Schroder Income Growth shares are held by company insiders. Comparatively, 0.1% of Bellevue Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Schroder Income Growth beats Bellevue Healthcare on 8 of the 12 factors compared between the two stocks.

Get Schroder Income Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCF vs. The Competition

MetricSchroder Income GrowthAsset Management IndustryFinancial SectorLON Exchange
Market Cap£202.82M£911.88M£3.20B£1.80B
Dividend Yield5.25%12.86%4.55%10.14%
P/E Ratio1,269.571,025.60479.192,127.68
Price / Sales10.831,743.451,900.60415,758.75
Price / Cash91.3359.0050.6626.89
Price / Book0.921.211.442.77
Net Income£16.26M£49.43M£345.11M£172.66M
7 Day Performance1.39%1.22%0.84%90.24%
1 Month Performance2.10%2.02%1.80%86.32%
1 Year Performance3.91%7.77%14.38%109.61%

Schroder Income Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
0 of 5 stars
0.00 / 5 stars
GBX 145.80
+1.0%
N/A-2.4%£797.02MN/A911.25N/A
JESC
JPMorgan European Smaller Companies Trust
0 of 5 stars
0.00 / 5 stars
N/AN/AN/A£795.72M£114.05M7.60N/APositive News
TFIF
TwentyFour Income
0 of 5 stars
0.00 / 5 stars
GBX 106.20
flat
N/A+9.6%£794.21MN/A-3,540.00N/ADividend Cut
News Coverage
SYNC
Syncona
1.8961 of 5 stars
1.90 / 5 stars
GBX 121
-1.6%
GBX 230
+90.1%
-21.4%£793.64M£-144,460,000.00-484.001,208Gap Down
TMPL
Temple Bar
0 of 5 stars
0.00 / 5 stars
GBX 272
+0.2%
N/A+19.8%£779.33M£95.25M937.93N/ANews Coverage
Positive News
APAX
Apax Global Alpha
0 of 5 stars
0.00 / 5 stars
GBX 157
+1.2%
N/A-14.2%£771.03M£67.10M1,744.44N/A
BGSC
BMO Global Smaller Companies
0 of 5 stars
0.00 / 5 stars
N/AN/A+0.0%£769.56M£303.85M2.77N/A
NBPE
NB Private Equity Partners
0 of 5 stars
0.00 / 5 stars
GBX 1,650
-0.4%
N/A+6.5%£762.96M£7.05M3,586.96N/A
VOF
VinaCapital Vietnam Opp Fund
0 of 5 stars
0.00 / 5 stars
GBX 492.50
+0.1%
N/A+11.8%£752.49M£201.32M-283.05125
ESCT
The European Smaller Companies Trust
0 of 5 stars
0.00 / 5 stars
GBX 186.40
+0.4%
N/A+19.1%£746.20M£91.68M932.00305

Related Companies and Tools

This page (LON:SCF) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners